MX365494B - Procedimiento de compuesto antifungico. - Google Patents
Procedimiento de compuesto antifungico.Info
- Publication number
- MX365494B MX365494B MX2016012056A MX2016012056A MX365494B MX 365494 B MX365494 B MX 365494B MX 2016012056 A MX2016012056 A MX 2016012056A MX 2016012056 A MX2016012056 A MX 2016012056A MX 365494 B MX365494 B MX 365494B
- Authority
- MX
- Mexico
- Prior art keywords
- antifungal compound
- compound process
- preparing compound
- useful
- antifungal
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229940125904 compound 1 Drugs 0.000 abstract 2
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Artificial Filaments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461955615P | 2014-03-19 | 2014-03-19 | |
| PCT/US2015/021491 WO2015143172A1 (en) | 2014-03-19 | 2015-03-19 | Antifungal compound process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016012056A MX2016012056A (es) | 2017-04-27 |
| MX365494B true MX365494B (es) | 2019-06-05 |
Family
ID=54145323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016012056A MX365494B (es) | 2014-03-19 | 2015-03-19 | Procedimiento de compuesto antifungico. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10173998B2 (enExample) |
| EP (1) | EP3119745B1 (enExample) |
| JP (1) | JP6509897B2 (enExample) |
| KR (1) | KR102151082B1 (enExample) |
| CN (2) | CN106458900B (enExample) |
| AU (1) | AU2015231226B2 (enExample) |
| BR (1) | BR112016020937B1 (enExample) |
| CA (1) | CA2942968C (enExample) |
| EA (1) | EA037587B1 (enExample) |
| ES (1) | ES2815373T3 (enExample) |
| HU (1) | HUE052446T2 (enExample) |
| MX (1) | MX365494B (enExample) |
| PL (1) | PL3119745T3 (enExample) |
| WO (1) | WO2015143172A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6572234B2 (ja) * | 2014-03-19 | 2019-09-04 | ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド | 抗真菌化合物の調製方法 |
| AU2015231275B2 (en) | 2014-03-19 | 2019-03-07 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| KR102441243B1 (ko) | 2014-03-19 | 2022-09-07 | 브이피에스-3, 엘엘씨 | 2-(2,4-디플루오르페닐)-1,1-디플루오르-1-(5-치환된-피리딘-2-일)-3-(1h-테트라졸-1-일)프로판-2-올 및 이의 제조방법 |
| AU2015231208B2 (en) * | 2014-03-19 | 2019-04-04 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| CA2942936A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| EP3119753B1 (en) | 2014-03-19 | 2020-11-04 | Dow AgroSciences LLC | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| WO2015143180A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| CA2942231A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| DK3271347T3 (da) * | 2015-03-19 | 2022-07-18 | Mycovia Pharmaceuticals Inc | Antifungale forbindelser og fremstillingsfremgangsmåder |
| HK1263287A1 (zh) * | 2015-09-18 | 2020-03-20 | Nqp 1598, Ltd. | 抗真菌化合物和制备方法 |
| US11213031B2 (en) | 2017-11-13 | 2022-01-04 | Bayer Aktiengesellschaft | Tetrazolylpropyl derivatives and their use as fungicides |
| AU2019325436B2 (en) * | 2018-08-18 | 2023-10-26 | 5Metis, Inc. | Solid forms of substituted benzoxaborole and compositions thereof |
| CN114573557B (zh) * | 2022-03-28 | 2024-03-08 | 浙江天宇药业股份有限公司 | 一种奥特康唑的制备方法 |
| CN116621816B (zh) * | 2022-09-23 | 2025-07-04 | 北京莱瑞森医药科技有限公司 | 一种伏立康唑对映异构对b的拆分方法 |
| CN116675672B (zh) * | 2023-06-05 | 2025-04-25 | 北京康立生医药技术开发有限公司 | 一种抗真菌药物的制备方法 |
| CN119798219B (zh) * | 2025-01-13 | 2025-07-18 | 长治医学院 | 一种奥特康唑的制备方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2854015B2 (de) | 1978-12-14 | 1980-10-09 | Dynamit Nobel Ag, 5210 Troisdorf | Verfahren zur Herstellung von !H-TetrazoI-1-essigsauren und bestimmter Ester derselben |
| JP2000344744A (ja) | 1999-06-04 | 2000-12-12 | Ss Pharmaceut Co Ltd | アセトフェノン誘導体およびその製法 |
| US8198448B2 (en) | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
| KR100889937B1 (ko) | 2007-08-06 | 2009-03-20 | 한미약품 주식회사 | 보리코나졸의 제조방법 |
| KR101109215B1 (ko) | 2009-06-17 | 2012-01-30 | 보령제약 주식회사 | 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법 |
| CN102803232A (zh) | 2009-06-18 | 2012-11-28 | 巴斯夫欧洲公司 | 杀真菌的具有5-硫取代基的1,2,4-三唑衍生物 |
| SI2563771T1 (sl) * | 2010-04-24 | 2016-05-31 | Viamet Pharmaceuticals, Inc. | Spojine inhibitorjev metaloencimov |
| BR122020013521B1 (pt) | 2011-06-19 | 2021-05-25 | Viamet Pharmaceuticals (NC), Inc | compostos inibidores de metaloenzima |
| EP2721021B1 (en) * | 2011-06-19 | 2019-01-23 | Viamet Pharmaceuticals (NC), Inc. | Metalloenzyme inhibitor compounds |
| CN103930418A (zh) | 2011-06-23 | 2014-07-16 | 威尔金制药有限公司 | 金属酶抑制剂化合物 |
| BR112014013963B1 (pt) * | 2011-12-11 | 2021-06-22 | Nqp 1598, Ltd | Compostos inibidores de metaloenzimas, composições compreendendo os ditos compostos, uso terapêutico dos mesmos e métodos para inibir a atividade de metaloenzimas e para tratar ou prevenir o crescimento de fungos em plantas |
| DK2804858T3 (da) * | 2012-01-20 | 2020-03-16 | Mycovia Pharmaceuticals Inc | Metalloenzym-inhibitorforbindelser |
| EP2804479A4 (en) | 2012-01-20 | 2015-07-22 | Viamet Pharmaceuticals Inc | METALLOENZYME INHIBITOR COMPOUNDS |
| WO2014043376A1 (en) | 2012-09-12 | 2014-03-20 | Dow Agrosciences Llc | Metalloenzyme inhibitor compounds |
| WO2014117090A1 (en) | 2013-01-28 | 2014-07-31 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| WO2014165861A1 (en) | 2013-04-05 | 2014-10-09 | The Regents Of The University Of California | Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds |
| WO2014193974A1 (en) | 2013-05-28 | 2014-12-04 | Viamet Pharmaceuticals, Inc. | Fungicidal compositions |
| KR20160018811A (ko) | 2013-06-12 | 2016-02-17 | 비아멧 파마슈티컬즈, 인코포레이티드 | 금속 효소 억제 화합물 |
| CA2942936A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| JP6572234B2 (ja) | 2014-03-19 | 2019-09-04 | ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド | 抗真菌化合物の調製方法 |
| WO2015143180A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| AU2015231275B2 (en) | 2014-03-19 | 2019-03-07 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| CA2942231A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| KR102441243B1 (ko) | 2014-03-19 | 2022-09-07 | 브이피에스-3, 엘엘씨 | 2-(2,4-디플루오르페닐)-1,1-디플루오르-1-(5-치환된-피리딘-2-일)-3-(1h-테트라졸-1-일)프로판-2-올 및 이의 제조방법 |
| AU2015231208B2 (en) | 2014-03-19 | 2019-04-04 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| US9802914B2 (en) | 2014-03-19 | 2017-10-31 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| EP3119753B1 (en) | 2014-03-19 | 2020-11-04 | Dow AgroSciences LLC | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| DK3271347T3 (da) | 2015-03-19 | 2022-07-18 | Mycovia Pharmaceuticals Inc | Antifungale forbindelser og fremstillingsfremgangsmåder |
| KR20180000731A (ko) | 2015-05-18 | 2018-01-03 | 비아멧 파마슈티컬즈, 인코포레이티드 | 항진균성 화합물 |
| HK1263287A1 (zh) | 2015-09-18 | 2020-03-20 | Nqp 1598, Ltd. | 抗真菌化合物和制备方法 |
| CA3005743A1 (en) | 2015-11-17 | 2017-05-26 | Dow Agrosciences Llc | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation |
| JP6963557B2 (ja) | 2015-11-17 | 2021-11-10 | コルテバ アグリサイエンス エルエルシー | ４−（（６−（２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−２−ヒドロキシ−３−（１ｈ−１，２，４−トリアゾール−１−イル）プロピル）ピリジン−３−イル）オキシ）ベンゾニトリル及び調製方法 |
| KR20180101343A (ko) | 2015-11-17 | 2018-09-12 | 다우 아그로사이언시즈 엘엘씨 | 4-((6-(2-(2,4-디플루오로페닐)-1,1-디플루오로-2-옥소에틸)피리딘-3-일)옥시)벤조니트릴 및 제조방법 |
| EP3377475A4 (en) | 2015-11-17 | 2019-04-10 | Dow Agrosciences Llc | 4 - ((6-2- (2,4-difluorophenyl) -1,1-difluoro-2-hydroxy-3- (1H-1,2,4-triazol-1-YL) PROPYL) PYRIDINE-3-YL ) OXY) BENZONITRIL AND METHOD OF PREPARING THEREOF |
| EA038421B1 (ru) | 2015-12-30 | 2021-08-26 | ВиПиЭс-3, ИНК. | Соединения, ингибирующие металлоферменты |
-
2015
- 2015-03-19 BR BR112016020937-0A patent/BR112016020937B1/pt active IP Right Grant
- 2015-03-19 CN CN201580014076.2A patent/CN106458900B/zh active Active
- 2015-03-19 US US15/126,402 patent/US10173998B2/en active Active
- 2015-03-19 JP JP2016557968A patent/JP6509897B2/ja active Active
- 2015-03-19 HU HUE15764743A patent/HUE052446T2/hu unknown
- 2015-03-19 PL PL15764743T patent/PL3119745T3/pl unknown
- 2015-03-19 EP EP15764743.9A patent/EP3119745B1/en active Active
- 2015-03-19 MX MX2016012056A patent/MX365494B/es active IP Right Grant
- 2015-03-19 EA EA201691649A patent/EA037587B1/ru unknown
- 2015-03-19 AU AU2015231226A patent/AU2015231226B2/en not_active Ceased
- 2015-03-19 ES ES15764743T patent/ES2815373T3/es active Active
- 2015-03-19 CN CN201811509148.2A patent/CN109970629B/zh active Active
- 2015-03-19 KR KR1020167025607A patent/KR102151082B1/ko active Active
- 2015-03-19 CA CA2942968A patent/CA2942968C/en active Active
- 2015-03-19 WO PCT/US2015/021491 patent/WO2015143172A1/en not_active Ceased
-
2019
- 2019-01-07 US US16/241,036 patent/US10392365B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3119745A1 (en) | 2017-01-25 |
| MX2016012056A (es) | 2017-04-27 |
| HUE052446T2 (hu) | 2021-04-28 |
| JP6509897B2 (ja) | 2019-05-08 |
| WO2015143172A1 (en) | 2015-09-24 |
| CN106458900A (zh) | 2017-02-22 |
| US10392365B2 (en) | 2019-08-27 |
| CA2942968A1 (en) | 2015-09-24 |
| EP3119745A4 (en) | 2017-08-23 |
| BR112016020937B1 (pt) | 2022-09-20 |
| AU2015231226A1 (en) | 2016-10-06 |
| AU2015231226B2 (en) | 2019-04-04 |
| PL3119745T3 (pl) | 2021-01-25 |
| BR112016020937A2 (enExample) | 2017-08-15 |
| EA201691649A1 (ru) | 2016-12-30 |
| US20170088539A1 (en) | 2017-03-30 |
| US10173998B2 (en) | 2019-01-08 |
| US20190161469A1 (en) | 2019-05-30 |
| JP2017509644A (ja) | 2017-04-06 |
| CN106458900B (zh) | 2019-01-01 |
| KR102151082B1 (ko) | 2020-09-03 |
| CA2942968C (en) | 2022-03-15 |
| KR20160138012A (ko) | 2016-12-02 |
| ES2815373T3 (es) | 2021-03-29 |
| EA037587B1 (ru) | 2021-04-19 |
| EP3119745B1 (en) | 2020-08-05 |
| CN109970629A (zh) | 2019-07-05 |
| CN109970629B (zh) | 2023-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016012056A (es) | Procedimiento de compuesto antifungico. | |
| MX2016012053A (es) | Procedimiento de compuesto antifungico. | |
| MX391538B (es) | Proceso de compuesto antifungico. | |
| GB201512314D0 (en) | Use of a composition containing 1,3-propanediol as an e-liquid | |
| MX2016016143A (es) | Compuestos de [1,2,4]triazol sustituido. | |
| PH12017500833A1 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| GEAP202014494A (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| JO3487B1 (ar) | تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به | |
| PH12016501865A1 (en) | Pyridine-2-amides useful as cb2 agonists | |
| PH12016501252A1 (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
| IN2014MU00455A (enExample) | ||
| MX2016009117A (es) | Pigmentos a base de compuestos de bismuto. | |
| EP3119899A4 (en) | Compositions and methods for producing chemicals and derivatives thereof | |
| MX2017002015A (es) | Ligando del receptor 2 de canabinoide radiomarcado. | |
| MX2017003550A (es) | Uso de cisteamina en tratamiento de infecciones causadas por levaduras/mohos. | |
| IN2014CH00151A (enExample) | ||
| MX2021000508A (es) | Extracto de sabadilla seco y fluido. | |
| EA201692246A1 (ru) | Способ получения 2,6-диметилбензохинона | |
| GB201707234D0 (en) | Composition & Process | |
| UA97937U (uk) | Матеріал для інтерференційних покриттів | |
| GB201607927D0 (en) | Composition & process | |
| GB201510891D0 (en) | Products, uses & methods (7) | |
| GB201509366D0 (en) | Products, uses & methods (6) | |
| GB201507774D0 (en) | Products, uses & methods (2) | |
| GB201507773D0 (en) | Products, uses & methods (1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status |
Owner name: REMOTE MEDIA, LLC |
|
| FG | Grant or registration |